Lava Therapeutics N.V. (LVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,908 | -608 | -41,871 | -35,258 | -26,472 |
| Depreciation Amortization | -1,078 | -531 | -1,288 | -285 | -280 |
| Accounts receivable | N/A | N/A | N/A | 2,146 | -683 |
| Accounts payable and accrued liabilities | -262 | -934 | 352 | 5,448 | 1,032 |
| Other Working Capital | -1,023 | -646 | -3,876 | 3,225 | 1,627 |
| Other Operating Activity | 2,214 | 1,876 | 6,400 | -3,783 | 3,376 |
| Operating Cash Flow | $-9,057 | $-843 | $-40,283 | $-28,507 | $-21,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 92 | 66 | -731 | -730 | -724 |
| Purchase Of Investment | -56,035 | -24,372 | -90,082 | -53,895 | -24,552 |
| Sale Of Investment | 57,000 | 25,000 | 73,177 | 45,677 | 33,177 |
| Investing Cash Flow | $1,057 | $694 | $-17,636 | $-8,948 | $7,901 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 235 |
| Common Stock Issued | 24 | 8 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | -736 | -489 |
| Financing Cash Flow | $24 | $8 | $N/A | $-736 | $-254 |
| Exchange Rate Effect | -1,168 | -903 | 1,817 | 521 | 1,027 |
| Beginning Cash Position | 44,231 | 44,231 | 100,333 | 100,333 | 100,333 |
| End Cash Position | 35,087 | 43,187 | 44,231 | 62,663 | 87,607 |
| Net Cash Flow | $-9,144 | $-1,044 | $-56,102 | $-37,670 | $-12,726 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,057 | -843 | -40,283 | -28,507 | -21,400 |
| Capital Expenditure | 92 | -23 | -731 | -730 | -724 |
| Free Cash Flow | -8,965 | -866 | -41,014 | -29,237 | -22,124 |